ALEMBIC OSELTAMIVIR oseltamivir (as phosphate) 45 mg hard capsule blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

oseltamivir phosphate, Quantity: 59.117 mg

Dostępny od:

Alembic Pharmaceuticals Australia Pty Ltd

Forma farmaceutyczna:

Capsule, hard

Skład:

Excipient Ingredients: povidone; sodium stearylfumarate; purified talc; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; purified water; Gelatin; iron oxide black; propylene glycol; indigo carmine; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution

Droga podania:

Oral

Sztuk w opakowaniu:

10

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Oseltamivir Phosphate is indicated for the treatment of infections due to influenza A and B viruses in adults and children including full-term neonates. Treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,Oseltamivir Phosphate is indicated for the prevention of influenza in adults and children aged 1 year and older. Vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Podsumowanie produktu:

Visual Identification: Opaque Grey cap/ opaque Grey body hard gelatin capsules size 4 having imprinting A 293 on cap with blue ink.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Status autoryzacji:

Registered

Data autoryzacji:

2022-11-17